Harold G Everett Jr., M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1205 E Front St, Port Angeles, WA 98362 Phone: 360-452-9708 Fax: 360-457-7249 |
Betsy L Kott-flodstrom, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 901 S Lincoln St, Port Angeles, WA 98362 Phone: 360-452-2022 Fax: 360-457-1686 |
News Archive
BioNTech AG, a fully integrated biotechnology company developing truly personalized cancer immunotherapies, announces that it has signed an agreement with Genmab A/S to jointly research, develop and commercialize multiple bispecific antibodies for cancer immunotherapy using proprietary technologies from both companies: BioNTech's proprietary immunomodulatory antibodies and Genmab's DuoBody technology platform.
The U.S. Food and Drug Administration today approved Yondelis (trabectedin), a chemotherapy, for the treatment of specific soft tissue sarcomas (STS) – liposarcoma and leiomyosarcoma – that cannot be removed by surgery (unresectable) or is advanced (metastatic).
People suffering from Alzheimer's and other forms of age-related dementia sometimes have trouble recognizing friends and family or knowing what to talk about when they visit.
Research published today in the journal Cell is the first to establish how a specific gut bacterium, activated Bifidobacterium infantis EVC001 (B. infantis), influences immune system development in infants, and could thereby reduce the risk of allergic and autoimmune conditions later in life.
› Verified 8 days ago